Identification of the function of gene lndM2 encoding a bifunctional oxygenase-reductase involved in the biosynthesis of the antitumor antibiotic landomycin E by Streptomyces globisporus 1912 supports the originally assigned structure for landomycinone

The angucycline antibiotic family of the landomycins displays potent antitumor activity. To elucidate early post polyketide synthase (PKS) tailoring steps of the landomycin E biosynthetic pathway in Streptomyces globisporus 1912, the mutant S. globisporus M12 was prepared through gene replacement experiment of lndM2. It encodes an enzyme with putative oxygenase and reductase domains, according to sequencing of the gene and its counterpart lanM2 from S. cyanogenus S136 landomycin A biosynthetic gene cluster. The isolation of the novel shunt products 11-hydroxytetrangomycin and 4-hydroxytetrangomycin along with the well-known angucyclines tetrangomycin and tetrangulol from the culture of S. globisporus M12 provides evidence for the involvement of lndM2 in the early biosynthetic pathway of the landomycins, in particular in the formation of the alicyclic 6-hydroxy function of the landomycin aglycon. We therefore propose LndM2 to be responsible for both hydroxylation of the 6-position and its subsequent reduction. These reactions are necessary before the glycosylation reactions can occur. The results are in agreement with the originally published structure of landomycin but do not support the recently suggested revised structure.     

Genes encoding enzymes responsible for biosynthesis of L-lyxose and attachment of eurekanate during avilamycin biosynthesis

The oligosaccharide antibiotic avilamycin A is composed of a polyketide-derived dichloroisoeverninic acid moiety attached to a heptasaccharide chain consisting of six hexoses and one unusual pentose moiety. We describe the generation of mutant strains of the avilamycin producer defective in different sugar biosynthetic genes. Inactivation of two genes (aviD and aviE2) resulted in the breakdown of the avilamycin biosynthesis. In contrast, avilamycin production was not influenced in an aviP mutant. Inactivation of aviGT4 resulted in a mutant that accumulated a novel avilamycin derivative lacking the terminal eurekanate residue. Finally, AviE2 was expressed in Escherichia coli and the gene product was characterized biochemically. AviE2 was shown to convert UDP-D-glucuronic acid to UDP-D-xylose, indicating that the pentose residue of avilamycin A is derived from D-glucose and not from D-ribose. Here we report a UDP-D-glucuronic acid decarboxylase in actinomycetes.     

The relation of cluster ion distributions to neutral cluster distributions in cluster beam experiments

One of the major problems in cluster beam experiments with uncharged clusters is to relate the detected distribution of cluster ions to the original distribution of the neutrals. Fragmentation of the clusters, differences in ionization efficiencies, and desorption of ligands for chemically reacted clusters distort the initial distribution. In this contribution the abundances of the neutral and the ionized particles will be related by rate equations in terms of phenomenological rate constants. Two approaches are chosen. In the more simple one the ionization and decay processes are fast and take place during the excitation pulse. In the second approach delayed processes are also allowed. In both cases recursion formulas are derived as analytical solutions of the coupled rate equations for the time evolution of the neutral and ionized cluster intensities. The general solutions contain a considerable number of parameters which have to be reduced by experimental conditions and observations. Applications are discussed.     

Carbonylniobium chemistry: II. Penta- and tetra-carbonylphosphineniobates(I)

A number of symmetrical and unsymmetrical bis-arene-ruthenium cations has been prepared and their reduction with sodium borohydride studied. Hydride hydrogen is shown to add preferentially to the less alkylated ring. The conditions are established, which allow the preparation of a new, previously unknown, cationic complex of arene-cyclohexadienyl-ruthenium by stepwise addition of hydride hydrogen.     

Structural Characterization of O‐ and C‐Glycosylating Variants of the Landomycin Glycosyltransferase LanGT2

The structures of the O‐glycosyltransferase LanGT2 and the engineered, C? C bond‐forming variant LanGT2S8Ac show how the replacement of a single loop can change the functionality of the enzyme. Crystal structures of the enzymes in complex with a nonhydrolyzable nucleotide‐sugar analogue revealed that there is a conformational transition to create the binding sites for the aglycon substrate. This induced‐fit transition was explored by molecular docking experiments with various aglycon substrates.